
Cefzox-SF 250mg/125mg Injection
Marketer
Elfin Pharma Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefzox-SF 250mg/125mg Injection
Cefzox-SF Injection (250mg/125mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby halting infection progression. Administration must be strictly under professional medical guidance. Consistent adherence to the prescribed treatment schedule is crucial; premature cessation can compromise efficacy. Complete the full course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent adverse reactions necessitate immediate medical consultation. Seek urgent medical attention for allergic manifestations such as rash, pruritus, edema, or respiratory distress. Prior to commencing treatment, inform your physician about all concurrent medications and existing health conditions. Expectant or nursing mothers require physician consultation before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and ample hydration will support recovery. Your doctor might order laboratory tests to monitor treatment response.
Uses of Cefzox-SF 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefzox-SF 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefzox-SF 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefzox-SF 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefzox-SF 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefzox-SF 250mg/125mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this by counteracting bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefzox-SF 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefzox-SF 250mg/125mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Cefzox-SF 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefzox-SF 250mg/125mg Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefzox-SF 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cefzox-SF 250mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Cefzox-SF 250mg/125mg Injection isn't advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Cefzox-SF 250mg/125mg Injection :
Omit a Cefzox-SF 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefzox-SF 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
